nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—Vismodegib—skin cancer	0.307	0.466	CbGbCtD
Auranofin—ALB—Vemurafenib—skin cancer	0.243	0.368	CbGbCtD
Auranofin—ALB—Fluorouracil—skin cancer	0.109	0.166	CbGbCtD
Auranofin—PRDX5—nipple—skin cancer	0.012	0.109	CbGeAlD
Auranofin—PRDX5—neck—skin cancer	0.0119	0.108	CbGeAlD
Auranofin—PRDX5—connective tissue—skin cancer	0.00852	0.0772	CbGeAlD
Auranofin—PRDX5—epithelium—skin cancer	0.00809	0.0733	CbGeAlD
Auranofin—PRDX5—skin of body—skin cancer	0.00769	0.0697	CbGeAlD
Auranofin—IKBKB—nipple—skin cancer	0.00711	0.0644	CbGeAlD
Auranofin—PRDX5—mammalian vulva—skin cancer	0.00702	0.0636	CbGeAlD
Auranofin—Hepatic enzyme increased—Vismodegib—skin cancer	0.00669	0.0345	CcSEcCtD
Auranofin—PRDX5—lymphoid tissue—skin cancer	0.00623	0.0564	CbGeAlD
Auranofin—PRDX5—female reproductive system—skin cancer	0.00601	0.0544	CbGeAlD
Auranofin—IKBKB—connective tissue—skin cancer	0.00504	0.0457	CbGeAlD
Auranofin—PRDX5—head—skin cancer	0.00502	0.0455	CbGeAlD
Auranofin—IKBKB—skin of body—skin cancer	0.00456	0.0413	CbGeAlD
Auranofin—IKBKB—mammalian vulva—skin cancer	0.00415	0.0376	CbGeAlD
Auranofin—Interstitial pneumonia—Temozolomide—skin cancer	0.00413	0.0213	CcSEcCtD
Auranofin—Proteinuria—Imiquimod—skin cancer	0.00379	0.0196	CcSEcCtD
Auranofin—Protein urine present—Imiquimod—skin cancer	0.00374	0.0193	CcSEcCtD
Auranofin—IKBKB—lymphoid tissue—skin cancer	0.00369	0.0334	CbGeAlD
Auranofin—Weight decreased—Vismodegib—skin cancer	0.00359	0.0185	CcSEcCtD
Auranofin—IKBKB—female reproductive system—skin cancer	0.00356	0.0322	CbGeAlD
Auranofin—Hepatic enzyme increased—Imiquimod—skin cancer	0.00352	0.0182	CcSEcCtD
Auranofin—PRDX5—lymph node—skin cancer	0.00351	0.0318	CbGeAlD
Auranofin—Interstitial lung disease—Bleomycin—skin cancer	0.00335	0.0172	CcSEcCtD
Auranofin—IKBKB—head—skin cancer	0.00297	0.0269	CbGeAlD
Auranofin—Interstitial lung disease—Temozolomide—skin cancer	0.00282	0.0146	CcSEcCtD
Auranofin—Alopecia—Vismodegib—skin cancer	0.00281	0.0145	CcSEcCtD
Auranofin—Interstitial pneumonia—Docetaxel—skin cancer	0.00275	0.0142	CcSEcCtD
Auranofin—Dysgeusia—Vismodegib—skin cancer	0.00271	0.014	CcSEcCtD
Auranofin—Dermatitis exfoliative—Imiquimod—skin cancer	0.00256	0.0132	CcSEcCtD
Auranofin—Eosinophilia—Vemurafenib—skin cancer	0.00243	0.0125	CcSEcCtD
Auranofin—Weight decreased—Vemurafenib—skin cancer	0.00222	0.0114	CcSEcCtD
Auranofin—Neuropathy peripheral—Vemurafenib—skin cancer	0.00214	0.011	CcSEcCtD
Auranofin—Hepatic enzyme increased—Temozolomide—skin cancer	0.00211	0.0109	CcSEcCtD
Auranofin—IKBKB—lymph node—skin cancer	0.00208	0.0189	CbGeAlD
Auranofin—Aplastic anaemia—Dactinomycin—skin cancer	0.00207	0.0107	CcSEcCtD
Auranofin—Dyspepsia—Vismodegib—skin cancer	0.00199	0.0102	CcSEcCtD
Auranofin—Pancytopenia—Imiquimod—skin cancer	0.00199	0.0102	CcSEcCtD
Auranofin—Decreased appetite—Vismodegib—skin cancer	0.00196	0.0101	CcSEcCtD
Auranofin—Constipation—Vismodegib—skin cancer	0.00193	0.00995	CcSEcCtD
Auranofin—Interstitial lung disease—Docetaxel—skin cancer	0.00188	0.00968	CcSEcCtD
Auranofin—Aplastic anaemia—Temozolomide—skin cancer	0.00188	0.00967	CcSEcCtD
Auranofin—Gastrointestinal pain—Vismodegib—skin cancer	0.00185	0.00952	CcSEcCtD
Auranofin—Eye disorder—Vemurafenib—skin cancer	0.00183	0.00946	CcSEcCtD
Auranofin—Neuropathy peripheral—Imiquimod—skin cancer	0.00183	0.00942	CcSEcCtD
Auranofin—Conjunctivitis—Imiquimod—skin cancer	0.00181	0.00934	CcSEcCtD
Auranofin—Abdominal pain—Vismodegib—skin cancer	0.00178	0.0092	CcSEcCtD
Auranofin—Alopecia—Vemurafenib—skin cancer	0.00173	0.00894	CcSEcCtD
Auranofin—Dysgeusia—Vemurafenib—skin cancer	0.00167	0.00863	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—PTGS2—skin cancer	0.00166	0.0448	CbGpPWpGaD
Auranofin—Visual impairment—Imiquimod—skin cancer	0.00161	0.00832	CcSEcCtD
Auranofin—Pruritus—Vismodegib—skin cancer	0.0016	0.00823	CcSEcCtD
Auranofin—Eye disorder—Imiquimod—skin cancer	0.00156	0.00807	CcSEcCtD
Auranofin—Diarrhoea—Vismodegib—skin cancer	0.00154	0.00796	CcSEcCtD
Auranofin—Dermatitis exfoliative—Temozolomide—skin cancer	0.00154	0.00792	CcSEcCtD
Auranofin—Alopecia—Imiquimod—skin cancer	0.00148	0.00763	CcSEcCtD
Auranofin—Vomiting—Vismodegib—skin cancer	0.00144	0.0074	CcSEcCtD
Auranofin—Rash—Vismodegib—skin cancer	0.00142	0.00734	CcSEcCtD
Auranofin—Dermatitis—Vismodegib—skin cancer	0.00142	0.00733	CcSEcCtD
Auranofin—Pancytopenia—Bleomycin—skin cancer	0.00141	0.00727	CcSEcCtD
Auranofin—Dysphagia—Dactinomycin—skin cancer	0.00139	0.00714	CcSEcCtD
Auranofin—Weight decreased—Bleomycin—skin cancer	0.00134	0.00693	CcSEcCtD
Auranofin—Nausea—Vismodegib—skin cancer	0.00134	0.00691	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00134	0.00689	CcSEcCtD
Auranofin—Angioedema—Imiquimod—skin cancer	0.00133	0.00686	CcSEcCtD
Auranofin—Pancytopenia—Dactinomycin—skin cancer	0.00132	0.00678	CcSEcCtD
Auranofin—Neutropenia—Dactinomycin—skin cancer	0.0013	0.00668	CcSEcCtD
Auranofin—Stomatitis—Bleomycin—skin cancer	0.00129	0.00666	CcSEcCtD
Auranofin—Haematuria—Bleomycin—skin cancer	0.00126	0.00651	CcSEcCtD
Auranofin—Dysphagia—Temozolomide—skin cancer	0.00125	0.00646	CcSEcCtD
Auranofin—ALB—lymph node—skin cancer	0.00121	0.011	CbGeAlD
Auranofin—Decreased appetite—Vemurafenib—skin cancer	0.00121	0.00625	CcSEcCtD
Auranofin—Stomatitis—Dactinomycin—skin cancer	0.0012	0.00621	CcSEcCtD
Auranofin—Constipation—Vemurafenib—skin cancer	0.00119	0.00615	CcSEcCtD
Auranofin—Pancytopenia—Temozolomide—skin cancer	0.00119	0.00614	CcSEcCtD
Auranofin—Neutropenia—Temozolomide—skin cancer	0.00117	0.00604	CcSEcCtD
Auranofin—Dysphagia—Fluorouracil—skin cancer	0.00115	0.00595	CcSEcCtD
Auranofin—Agranulocytosis—Dactinomycin—skin cancer	0.00115	0.00594	CcSEcCtD
Auranofin—Eosinophilia—Fluorouracil—skin cancer	0.00114	0.00589	CcSEcCtD
Auranofin—Weight decreased—Temozolomide—skin cancer	0.00113	0.00585	CcSEcCtD
Auranofin—Anorexia—Imiquimod—skin cancer	0.00113	0.00584	CcSEcCtD
Auranofin—Pancytopenia—Fluorouracil—skin cancer	0.0011	0.00565	CcSEcCtD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—SHH—skin cancer	0.0011	0.0296	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Temozolomide—skin cancer	0.0011	0.00565	CcSEcCtD
Auranofin—Stomatitis—Temozolomide—skin cancer	0.00109	0.00562	CcSEcCtD
Auranofin—Alopecia—Bleomycin—skin cancer	0.00105	0.00542	CcSEcCtD
Auranofin—Dyspepsia—Imiquimod—skin cancer	0.00105	0.0054	CcSEcCtD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—PTCH1—skin cancer	0.00104	0.0281	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—SMO—skin cancer	0.00104	0.0281	CbGpPWpGaD
Auranofin—Decreased appetite—Imiquimod—skin cancer	0.00103	0.00533	CcSEcCtD
Auranofin—Neuropathy peripheral—Fluorouracil—skin cancer	0.00101	0.0052	CcSEcCtD
Auranofin—Stomatitis—Fluorouracil—skin cancer	0.001	0.00517	CcSEcCtD
Auranofin—Conjunctivitis—Fluorouracil—skin cancer	0.001	0.00516	CcSEcCtD
Auranofin—Pruritus—Vemurafenib—skin cancer	0.000987	0.00509	CcSEcCtD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—MITF—skin cancer	0.000984	0.0266	CbGpPWpGaD
Auranofin—Alopecia—Dactinomycin—skin cancer	0.00098	0.00505	CcSEcCtD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TLR7—skin cancer	0.000977	0.0264	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Imiquimod—skin cancer	0.000973	0.00501	CcSEcCtD
Auranofin—Visual impairment—Temozolomide—skin cancer	0.000967	0.00498	CcSEcCtD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	0.000965	0.0261	CbGpPWpGaD
Auranofin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000964	0.00497	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—CDK4—skin cancer	0.000962	0.026	CbGpPWpGaD
Auranofin—Agranulocytosis—Fluorouracil—skin cancer	0.000961	0.00495	CcSEcCtD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—TLR7—skin cancer	0.000959	0.0259	CbGpPWpGaD
Auranofin—Anaemia—Bleomycin—skin cancer	0.000957	0.00493	CcSEcCtD
Auranofin—Diarrhoea—Vemurafenib—skin cancer	0.000954	0.00492	CcSEcCtD
Auranofin—Urticaria—Imiquimod—skin cancer	0.000945	0.00487	CcSEcCtD
Auranofin—Abdominal pain—Imiquimod—skin cancer	0.00094	0.00485	CcSEcCtD
Auranofin—Eye disorder—Temozolomide—skin cancer	0.000937	0.00483	CcSEcCtD
Auranofin—Leukopenia—Bleomycin—skin cancer	0.000927	0.00478	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—TLR7—skin cancer	0.000926	0.025	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—IL6—skin cancer	0.000902	0.0244	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—SHH—skin cancer	0.000896	0.0242	CbGpPWpGaD
Auranofin—Anaemia—Dactinomycin—skin cancer	0.000892	0.0046	CcSEcCtD
Auranofin—Vomiting—Vemurafenib—skin cancer	0.000887	0.00457	CcSEcCtD
Auranofin—Alopecia—Temozolomide—skin cancer	0.000886	0.00457	CcSEcCtD
Auranofin—Rash—Vemurafenib—skin cancer	0.000879	0.00453	CcSEcCtD
Auranofin—Dermatitis—Vemurafenib—skin cancer	0.000878	0.00453	CcSEcCtD
Auranofin—Leukopenia—Dactinomycin—skin cancer	0.000864	0.00446	CcSEcCtD
Auranofin—Dysgeusia—Temozolomide—skin cancer	0.000855	0.00441	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TLR7—skin cancer	0.000852	0.0231	CbGpPWpGaD
Auranofin—Pruritus—Imiquimod—skin cancer	0.000841	0.00434	CcSEcCtD
Auranofin—Dysphagia—Docetaxel—skin cancer	0.000833	0.0043	CcSEcCtD
Auranofin—Nausea—Vemurafenib—skin cancer	0.000828	0.00427	CcSEcCtD
Auranofin—Thrombocytopenia—Bleomycin—skin cancer	0.000827	0.00426	CcSEcCtD
Auranofin—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	0.000826	0.0223	CbGpPWpGaD
Auranofin—Alopecia—Fluorouracil—skin cancer	0.000817	0.00421	CcSEcCtD
Auranofin—Diarrhoea—Imiquimod—skin cancer	0.000814	0.0042	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—RASA1—skin cancer	0.000808	0.0218	CbGpPWpGaD
Auranofin—Anaemia—Temozolomide—skin cancer	0.000807	0.00416	CcSEcCtD
Auranofin—Anorexia—Bleomycin—skin cancer	0.000805	0.00415	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MSH2—skin cancer	0.000802	0.0217	CbGpPWpGaD
Auranofin—Angioedema—Temozolomide—skin cancer	0.000798	0.00411	CcSEcCtD
Auranofin—Pancytopenia—Docetaxel—skin cancer	0.000792	0.00408	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—FOXO4—skin cancer	0.000789	0.0214	CbGpPWpGaD
Auranofin—Leukopenia—Temozolomide—skin cancer	0.000782	0.00403	CcSEcCtD
Auranofin—Neutropenia—Docetaxel—skin cancer	0.000779	0.00402	CcSEcCtD
Auranofin—Thrombocytopenia—Dactinomycin—skin cancer	0.000772	0.00398	CcSEcCtD
Auranofin—IKBKB—Estrogen signaling pathway—BRAF—skin cancer	0.000765	0.0207	CbGpPWpGaD
Auranofin—Vomiting—Imiquimod—skin cancer	0.000756	0.0039	CcSEcCtD
Auranofin—Weight decreased—Docetaxel—skin cancer	0.000754	0.00389	CcSEcCtD
Auranofin—Anorexia—Dactinomycin—skin cancer	0.000751	0.00387	CcSEcCtD
Auranofin—Rash—Imiquimod—skin cancer	0.00075	0.00387	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—RASA1—skin cancer	0.000749	0.0203	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—RASA1—skin cancer	0.000749	0.0203	CbGpPWpGaD
Auranofin—Dermatitis—Imiquimod—skin cancer	0.000749	0.00386	CcSEcCtD
Auranofin—Anaemia—Fluorouracil—skin cancer	0.000744	0.00383	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—CDKN2A—skin cancer	0.000735	0.0199	CbGpPWpGaD
Auranofin—Decreased appetite—Bleomycin—skin cancer	0.000734	0.00379	CcSEcCtD
Auranofin—Neuropathy peripheral—Docetaxel—skin cancer	0.000728	0.00376	CcSEcCtD
Auranofin—Stomatitis—Docetaxel—skin cancer	0.000724	0.00373	CcSEcCtD
Auranofin—Jaundice—Docetaxel—skin cancer	0.000724	0.00373	CcSEcCtD
Auranofin—Conjunctivitis—Docetaxel—skin cancer	0.000722	0.00372	CcSEcCtD
Auranofin—Leukopenia—Fluorouracil—skin cancer	0.00072	0.00371	CcSEcCtD
Auranofin—Nausea—Imiquimod—skin cancer	0.000706	0.00364	CcSEcCtD
Auranofin—Thrombocytopenia—Temozolomide—skin cancer	0.000698	0.0036	CcSEcCtD
Auranofin—Agranulocytosis—Docetaxel—skin cancer	0.000694	0.00358	CcSEcCtD
Auranofin—Decreased appetite—Dactinomycin—skin cancer	0.000685	0.00353	CcSEcCtD
Auranofin—Anorexia—Temozolomide—skin cancer	0.000679	0.0035	CcSEcCtD
Auranofin—Urticaria—Bleomycin—skin cancer	0.000671	0.00346	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR7—skin cancer	0.000665	0.018	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—TLR7—skin cancer	0.000658	0.0178	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000644	0.00332	CcSEcCtD
Auranofin—Thrombocytopenia—Fluorouracil—skin cancer	0.000643	0.00331	CcSEcCtD
Auranofin—Visual impairment—Docetaxel—skin cancer	0.000643	0.00331	CcSEcCtD
Auranofin—Dyspepsia—Temozolomide—skin cancer	0.000627	0.00323	CcSEcCtD
Auranofin—Anorexia—Fluorouracil—skin cancer	0.000626	0.00323	CcSEcCtD
Auranofin—Eye disorder—Docetaxel—skin cancer	0.000623	0.00321	CcSEcCtD
Auranofin—Abdominal pain—Dactinomycin—skin cancer	0.000623	0.00321	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—FOXO4—skin cancer	0.000622	0.0168	CbGpPWpGaD
Auranofin—Decreased appetite—Temozolomide—skin cancer	0.00062	0.00319	CcSEcCtD
Auranofin—Constipation—Temozolomide—skin cancer	0.000609	0.00314	CcSEcCtD
Auranofin—Pruritus—Bleomycin—skin cancer	0.000598	0.00308	CcSEcCtD
Auranofin—Alopecia—Docetaxel—skin cancer	0.00059	0.00304	CcSEcCtD
Auranofin—Gastrointestinal pain—Temozolomide—skin cancer	0.000583	0.003	CcSEcCtD
Auranofin—Dyspepsia—Fluorouracil—skin cancer	0.000578	0.00298	CcSEcCtD
Auranofin—Decreased appetite—Fluorouracil—skin cancer	0.000571	0.00294	CcSEcCtD
Auranofin—Dysgeusia—Docetaxel—skin cancer	0.000569	0.00293	CcSEcCtD
Auranofin—Urticaria—Temozolomide—skin cancer	0.000566	0.00292	CcSEcCtD
Auranofin—Abdominal pain—Temozolomide—skin cancer	0.000563	0.0029	CcSEcCtD
Auranofin—Diarrhoea—Dactinomycin—skin cancer	0.000539	0.00278	CcSEcCtD
Auranofin—Vomiting—Bleomycin—skin cancer	0.000537	0.00277	CcSEcCtD
Auranofin—Anaemia—Docetaxel—skin cancer	0.000537	0.00277	CcSEcCtD
Auranofin—Rash—Bleomycin—skin cancer	0.000533	0.00275	CcSEcCtD
Auranofin—Dermatitis—Bleomycin—skin cancer	0.000532	0.00274	CcSEcCtD
Auranofin—Urticaria—Fluorouracil—skin cancer	0.000522	0.00269	CcSEcCtD
Auranofin—Leukopenia—Docetaxel—skin cancer	0.00052	0.00268	CcSEcCtD
Auranofin—Pruritus—Temozolomide—skin cancer	0.000504	0.0026	CcSEcCtD
Auranofin—Nausea—Bleomycin—skin cancer	0.000502	0.00259	CcSEcCtD
Auranofin—Vomiting—Dactinomycin—skin cancer	0.000501	0.00258	CcSEcCtD
Auranofin—Rash—Dactinomycin—skin cancer	0.000497	0.00256	CcSEcCtD
Auranofin—Diarrhoea—Temozolomide—skin cancer	0.000488	0.00251	CcSEcCtD
Auranofin—Nausea—Dactinomycin—skin cancer	0.000468	0.00241	CcSEcCtD
Auranofin—Pruritus—Fluorouracil—skin cancer	0.000465	0.0024	CcSEcCtD
Auranofin—Thrombocytopenia—Docetaxel—skin cancer	0.000464	0.00239	CcSEcCtD
Auranofin—Vomiting—Temozolomide—skin cancer	0.000453	0.00234	CcSEcCtD
Auranofin—Anorexia—Docetaxel—skin cancer	0.000452	0.00233	CcSEcCtD
Auranofin—Rash—Temozolomide—skin cancer	0.000449	0.00232	CcSEcCtD
Auranofin—Diarrhoea—Fluorouracil—skin cancer	0.000449	0.00232	CcSEcCtD
Auranofin—Dermatitis—Temozolomide—skin cancer	0.000449	0.00231	CcSEcCtD
Auranofin—Nausea—Temozolomide—skin cancer	0.000423	0.00218	CcSEcCtD
Auranofin—Vomiting—Fluorouracil—skin cancer	0.000418	0.00215	CcSEcCtD
Auranofin—Dyspepsia—Docetaxel—skin cancer	0.000417	0.00215	CcSEcCtD
Auranofin—Rash—Fluorouracil—skin cancer	0.000414	0.00213	CcSEcCtD
Auranofin—Dermatitis—Fluorouracil—skin cancer	0.000414	0.00213	CcSEcCtD
Auranofin—Decreased appetite—Docetaxel—skin cancer	0.000412	0.00212	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—TP53—skin cancer	0.000409	0.0111	CbGpPWpGaD
Auranofin—Constipation—Docetaxel—skin cancer	0.000405	0.00209	CcSEcCtD
Auranofin—Nausea—Fluorouracil—skin cancer	0.00039	0.00201	CcSEcCtD
Auranofin—Gastrointestinal pain—Docetaxel—skin cancer	0.000388	0.002	CcSEcCtD
Auranofin—Abdominal pain—Docetaxel—skin cancer	0.000375	0.00193	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—IL6—skin cancer	0.000374	0.0101	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—RASA1—skin cancer	0.000359	0.00971	CbGpPWpGaD
Auranofin—Pruritus—Docetaxel—skin cancer	0.000335	0.00173	CcSEcCtD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN2A—skin cancer	0.000334	0.00903	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—BRAF—skin cancer	0.000329	0.0089	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—NRAS—skin cancer	0.000329	0.00889	CbGpPWpGaD
Auranofin—Diarrhoea—Docetaxel—skin cancer	0.000324	0.00167	CcSEcCtD
Auranofin—Vomiting—Docetaxel—skin cancer	0.000301	0.00155	CcSEcCtD
Auranofin—Rash—Docetaxel—skin cancer	0.000299	0.00154	CcSEcCtD
Auranofin—Dermatitis—Docetaxel—skin cancer	0.000299	0.00154	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FOXO4—skin cancer	0.000296	0.00801	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—KRAS—skin cancer	0.000283	0.00765	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—FOXO4—skin cancer	0.000283	0.00764	CbGpPWpGaD
Auranofin—Nausea—Docetaxel—skin cancer	0.000282	0.00145	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—FOXO4—skin cancer	0.000261	0.00707	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—NRAS—skin cancer	0.000246	0.00667	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—BRAF—skin cancer	0.000242	0.00654	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—HRAS—skin cancer	0.00024	0.0065	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CDKN2A—skin cancer	0.000234	0.00634	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000233	0.0063	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—skin cancer	0.00022	0.00595	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR7—skin cancer	0.000213	0.00576	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—KRAS—skin cancer	0.000212	0.00574	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—HRAS—skin cancer	0.000209	0.00566	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—skin cancer	0.000208	0.00562	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—NRAS—skin cancer	0.000207	0.00559	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—NRAS—skin cancer	0.000207	0.00559	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NRAS—skin cancer	0.000204	0.00553	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RHOU—skin cancer	0.000202	0.00545	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FOXO4—skin cancer	0.000192	0.00521	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—skin cancer	0.00018	0.00488	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—KRAS—skin cancer	0.000178	0.00481	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—KRAS—skin cancer	0.000178	0.00481	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—KRAS—skin cancer	0.000176	0.00476	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—skin cancer	0.000161	0.00436	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—NRAS—skin cancer	0.000159	0.00429	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—skin cancer	0.000156	0.00423	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—BRAF—skin cancer	0.000156	0.00421	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—skin cancer	0.000153	0.00413	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—skin cancer	0.000151	0.00409	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—HRAS—skin cancer	0.000151	0.00409	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—HRAS—skin cancer	0.000149	0.00404	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—skin cancer	0.000149	0.00404	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—NRAS—skin cancer	0.000139	0.00377	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—HRAS—skin cancer	0.000137	0.00369	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000136	0.00369	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000131	0.00355	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—skin cancer	0.000131	0.00354	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—skin cancer	0.00013	0.00353	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR7—skin cancer	0.000124	0.00336	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—skin cancer	0.000122	0.00331	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—KRAS—skin cancer	0.00012	0.00325	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000118	0.0032	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—skin cancer	0.000118	0.0032	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—HRAS—skin cancer	0.000118	0.00319	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	0.000117	0.00317	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—HRAS—skin cancer	0.000116	0.00314	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	0.000115	0.00311	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—skin cancer	0.000113	0.00306	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	0.000112	0.00302	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—skin cancer	0.000111	0.00301	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000111	0.003	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—skin cancer	0.000111	0.003	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FOXO4—skin cancer	0.00011	0.00297	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—skin cancer	0.000109	0.00295	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FOXO4—skin cancer	0.000105	0.00285	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—skin cancer	0.000105	0.00283	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000102	0.00276	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—skin cancer	0.000102	0.00276	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—BRAF—skin cancer	0.000102	0.00275	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTCH2—skin cancer	9.84e-05	0.00266	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	9.84e-05	0.00266	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NRAS—skin cancer	9.79e-05	0.00265	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—skin cancer	9.76e-05	0.00264	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—skin cancer	9.42e-05	0.00255	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—skin cancer	9.41e-05	0.00254	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	9.39e-05	0.00254	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	8.86e-05	0.0024	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NRAS—skin cancer	8.69e-05	0.00235	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	8.47e-05	0.00229	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—skin cancer	8.43e-05	0.00228	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—skin cancer	8.36e-05	0.00226	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—skin cancer	8.11e-05	0.00219	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	8.08e-05	0.00219	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	7.98e-05	0.00216	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—skin cancer	7.89e-05	0.00213	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—skin cancer	7.65e-05	0.00207	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—skin cancer	7.49e-05	0.00203	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—skin cancer	7.48e-05	0.00202	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GLI2—skin cancer	7.46e-05	0.00202	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—skin cancer	7.45e-05	0.00202	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	7.2e-05	0.00195	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MC1R—skin cancer	7.12e-05	0.00193	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GLI1—skin cancer	7.01e-05	0.0019	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	6.87e-05	0.00186	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SUFU—skin cancer	6.65e-05	0.0018	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	6.58e-05	0.00178	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NRAS—skin cancer	6.51e-05	0.00176	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRAS—skin cancer	6.4e-05	0.00173	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FOXO4—skin cancer	6.39e-05	0.00173	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—skin cancer	6.36e-05	0.00172	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—skin cancer	6.08e-05	0.00164	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLIN2—skin cancer	5.85e-05	0.00158	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—skin cancer	5.6e-05	0.00152	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—skin cancer	5.51e-05	0.00149	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SHH—skin cancer	5.07e-05	0.00137	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RASA1—skin cancer	5.04e-05	0.00136	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTCH1—skin cancer	4.81e-05	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMO—skin cancer	4.81e-05	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—skin cancer	4.76e-05	0.00129	CbGpPWpGaD
Auranofin—ALB—Metabolism—CSPG4—skin cancer	4.72e-05	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—skin cancer	4.68e-05	0.00127	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTGER4—skin cancer	4.68e-05	0.00127	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—skin cancer	4.56e-05	0.00123	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—skin cancer	4.48e-05	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FOXO4—skin cancer	4.13e-05	0.00112	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—skin cancer	3.65e-05	0.000987	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—skin cancer	3.5e-05	0.000948	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO2—skin cancer	3.21e-05	0.000867	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—skin cancer	3.14e-05	0.00085	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—skin cancer	3.02e-05	0.000816	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—skin cancer	2.76e-05	0.000747	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—skin cancer	2.67e-05	0.000722	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—skin cancer	2.56e-05	0.000693	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—skin cancer	2.56e-05	0.000691	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.51e-05	0.000678	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BRAF—skin cancer	2.19e-05	0.000591	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—skin cancer	2.14e-05	0.00058	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—skin cancer	2.13e-05	0.000575	CbGpPWpGaD
Auranofin—ALB—Metabolism—ERCC2—skin cancer	1.86e-05	0.000504	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—skin cancer	1.84e-05	0.000499	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—skin cancer	1.83e-05	0.000495	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—skin cancer	1.64e-05	0.000443	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—skin cancer	1.57e-05	0.000424	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—skin cancer	1.56e-05	0.000421	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—skin cancer	1.49e-05	0.000403	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—skin cancer	1.37e-05	0.000372	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—skin cancer	1.18e-05	0.00032	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—skin cancer	1.12e-05	0.000302	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—skin cancer	1.05e-05	0.000284	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—skin cancer	1.01e-05	0.000272	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—skin cancer	9.62e-06	0.00026	CbGpPWpGaD
